Last reviewed · How we verify
NCT06076798
Clinical Performance of AFGen1
trial testing ECG co-measurement in Atrial Fibrillation in 15 participants. Completed in 24 November 2023.
5 November 2023
Quick facts
| Lead sponsor | TriVirum, Inc. |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 15 |
| Start date | 5 October 2023 |
| Primary completion | 5 November 2023 |
| Estimated completion | 24 November 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- ECG co-measurement
Conditions studied
- Atrial Fibrillation — all drugs for Atrial Fibrillation →
- Afib — all drugs for Afib →
- ECG — all drugs for ECG →
Sponsor
TriVirum, Inc.
Who can join
Adults 18 to 90, any sex, with Atrial Fibrillation or Afib. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
AFGen1 is indicated for use on symptomatic or asymptomatic adults who are at risk of developing or who have atrial fibrillation, where a software assisted analysis of ambulatory ECG is needed to identify episodes of Afib. The purpose of this study is to establish the clinical performance of AFGen1 on human participants.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06076798
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of ECG co-measurement
Trials testing the same drug.
- NCT06335498 — Further Study of AFGen1 Clinical Performance · completed
Other recruiting trials for Atrial Fibrillation
Currently open trials in the same condition.
- NCT07429214 — A Study of VARIPULSE Catheter and TRUPULSE Generator With VARIPULSE Pro Software in Participants With PAF or PsAF · NA · recruiting
- NCT07271238 — Feasibility Study on the VERAFEYE Imaging and Navigation System for Guided Catheter Ablation Procedures · NA · recruiting
- NCT07388108 — Atrial Dyssynchrony to Predict Arrhythmias in the Postoperative Setting of Cardiovascular Surgery. · recruiting
- NCT07428967 — AV Node Ablation and CONDUCTion System Pacing for Atrial Fibrillation With Preserved Left Ventricular Function · NA · recruiting
- NCT06650995 — AlEX-DHF: Ablation and Exercise in Diastolic Heart Failure · NA · recruiting
Other TriVirum, Inc. trials
Trials by the same sponsor.
- NCT06335498 — Further Study of AFGen1 Clinical Performance · completed
- NCT05295056 — Clinical Performance of the AFGen1 Device Over a 7-day Period · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06076798 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by TriVirum, Inc.
- Last refreshed: 11 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06076798.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing